Allogene Therapeutics, Inc. (ALLO)
1.82
-0.03
(-1.62%)
USD |
NASDAQ |
Jun 09, 16:00
1.835
+0.02
(+0.82%)
After-Hours: 20:00
Allogene Therapeutics EPS Diluted (Quarterly) : -0.1773 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ALX Oncology Holdings, Inc. | -0.1714 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.61M |
| Total Expenses (Quarterly) | 42.61M |
| Enterprise Value | 259.73M |
| Earnings Yield | -42.20% |
| Normalized Earnings Yield | -41.79 |